Evotec’s Protein Sciences team applies extensive expertise and advanced technologies to deliver a broad spectrum of biologics, including monoclonal antibodies, bispecific antibodies, antibody fragments, Fc-fusion proteins, and TCRs. 

The team provides flexible biologics production services that support all stages of antibody drug discovery and development, ranging from high-throughput antibody panel generation to multi-gram production of lead candidates. 

To streamline candidate selection and reduce development risk, high-throughput characterization platforms are used to assess developability properties in parallel with binding and functional data, ensuring high-quality biologics ready for downstream applications.

Evotec supports antibody drug development with scalable production, from high-throughput transient expression to stable multigram manufacturing. Early and extended developability assessments ensure high-quality biologics, including monoclonal and bispecific antibodies, fragments, and Fc-fusions.

Protein Production Services for Antibody Drug Development

Antibody Production Services at Evotec

  • Efficient scaling capabilities from 2 ml to 30 L
  • High-titer antibody production for micro- to multi-gram quantities
  • Customized services tailored to purity and low-endotoxin requirements
  • Integrated developability assessment packages to de-risk biologics development
Evotec’s biologics production workflow spans gene synthesis, DNA preparation, scalable antibody production, and characterization, delivering high-quality biologics in as little as three weeks.

End-to-End Biologics Production Workflow

Comprehensive Antibody Discovery & Development Services

Evotec delivers end-to-end antibody solutions, ensuring high-quality biologics are produced, characterized, and optimized for discovery and development.

James Errey

Dr. James Errey

VP, Head of Global Protein Production

vCard
Logo Evotec white
Evotec has the right technologies & disease understanding to meet our partners' evolving needs: a comprehensive disease knowledge at the molecular level, cutting-edge technologies & platforms to translate this expertise into effective precision medicines.